Site-specific crosslinking of human microRNPs to RNA targets

Yohei Kirino1, Zissimos Mourelatos

  • 1Division of Neuropathology, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

RNA (New York, N.Y.)
|August 23, 2008
PubMed

Insights

MicroRNAs (miRNAs) guide protein complexes to target messenger RNAs. Researchers adapted a crosslinking method to find that only Ago proteins bind to these sites in a miRNA-dependent way.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression.
  • Dysregulation of miRNAs is linked to various human diseases.
  • miRNAs direct microprotein complexes (miRNPs) to specific sites on messenger RNA (mRNA) targets, known as miRNA recognition elements (MREs).

Purpose of the Study:

  • To identify protein factors that physically associate with MREs in human cells.
  • To understand the role of these proteins in miRNA-mediated gene regulation.

Main Methods:

  • Adaptation of a site-specific crosslinking approach, originally used for splicing analysis.
  • Interrogation of protein factors binding to MREs in human cells.

Main Results:

  • Ago proteins were identified as the sole proteins binding to MREs.
  • This binding is dependent on the presence of miRNA.
  • The study provides a method to analyze MRE-bound complexes.

Conclusions:

  • Ago proteins are the primary interactors with MREs in a miRNA-dependent manner.
  • The developed crosslinking method is a valuable tool for studying miRNA-target interactions.
  • This research deepens the understanding of miRNA-mediated gene regulation mechanisms.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...